Project Details
Status | Finished |
---|---|
Effective start/end date | 1/11/2013 → 31/08/2017 |
Collaborative partners
- King's College London (lead)
- BBSRC Biotechnology and Biological Sciences Research Council
- GlaxoSmithKline USA
Funding
- BBSRC Biotechnology and Biological Sciences Research Council: £387,446.00
- GSK GlaxoSmithKline Research & Development Ltd: £53,000.00